Published in Birth Defects Res A Clin Mol Teratol on February 28, 2012
Maternal age, parity and isolated birth defects: a population-based case-control study in Shenzhen, China. PLoS One (2013) 0.90
Nongenetic risk factors and congenital heart defects. Pediatr Cardiol (2013) 0.90
Diabetes and congenital heart defects: a systematic review, meta-analysis, and modeling project. Am J Prev Med (2014) 0.81
Maternal parity and the risk of congenital heart defects in offspring: a dose-response meta-analysis of epidemiological observational studies. PLoS One (2014) 0.80
Maternal age and birth defects after the use of assisted reproductive technology in Japan, 2004-2010. Int J Womens Health (2013) 0.80
Maternal diet supplementation with methyl donors and increased parity affect the incidence of craniofacial defects in the offspring of twisted gastrulation mutant mice. J Nutr (2013) 0.78
Risk estimates of recurrent congenital anomalies in the UK: a population-based register study. BMC Med (2017) 0.75
Risk factors and demographics for microtia in South America: a case-control analysis. Birth Defects Res A Clin Mol Teratol (2013) 0.75
Combining adverse pregnancy and perinatal outcomes for women exposed to antiepileptic drugs during pregnancy, using a latent trait model. BMC Pregnancy Childbirth (2017) 0.75
Proportion of selected congenital heart defects attributable to recognized risk factors. Ann Epidemiol (2016) 0.75
Deliveries and children born after in-vitro fertilisation in Sweden 1982-95: a retrospective cohort study. Lancet (1999) 5.63
The National Birth Defects Prevention Study. Public Health Rep (2001) 5.50
Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75
Diabetes mellitus and birth defects. Am J Obstet Gynecol (2008) 3.25
Risk factor patterns for cryptorchidism and hypospadias. Epidemiology (1999) 2.64
Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod (2008) 2.38
Birth order and oral clefts: a meta analysis. Teratology (2002) 1.79
The epidemiology of cardiovascular defects, part I: a study based on data from three large registries of congenital malformations. Pediatr Cardiol (2003) 1.76
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A (2008) 1.63
Infertility, infertility treatment, and congenital malformations: Danish national birth cohort. BMJ (2006) 1.63
Higher maternal levels of free estradiol in first compared to second pregnancy: early gestational differences. J Natl Cancer Inst (1986) 1.54
Epidemiologic characteristics of congenital diaphragmatic hernia among 2.5 million California births, 1989-1997. Birth Defects Res A Clin Mol Teratol (2006) 1.43
Isolated esophageal atresia and perinatal risk factors. Dis Esophagus (2003) 1.41
Hypospadias in California: trends and descriptive epidemiology. Epidemiology (2003) 1.39
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
Including prenatal diagnoses in birth defects monitoring: Experience of the Metropolitan Atlanta Congenital Defects Program. Birth Defects Res A Clin Mol Teratol (2009) 1.33
Prevalence of nonsyndromic oral clefts in Texas: 1995-1999. Am J Med Genet A (2005) 1.21
Maternal vasoactive exposures, amniotic bands, and terminal transverse limb defects. Birth Defects Res A Clin Mol Teratol (2009) 1.18
Variation in the decision to terminate pregnancy in the setting of fetal aneuploidy. Prenat Diagn (2006) 1.18
Urban-rural residence and the occurrence of cleft lip and cleft palate in Texas, 1999-2003. Ann Epidemiol (2010) 1.15
Maternal reproductive and demographic characteristics as risk factors for hypospadias. Paediatr Perinat Epidemiol (2007) 1.13
Effect of interpregnancy interval on adverse perinatal outcomes--a national study. Contraception (2009) 1.09
The epidemiology of anotia and microtia. J Med Genet (1996) 1.09
Demographic and environmental risk factors for gastroschisis and omphalocele in the National Birth Defects Prevention Study. J Pediatr Surg (2009) 1.04
The prevalence and predictors of anencephaly and spina bifida in Texas. Paediatr Perinat Epidemiol (2009) 1.02
Epidemiologic analysis of maternal factors and amniotic band defects. Birth Defects Res A Clin Mol Teratol (2003) 1.01
Blood pressure during pregnancy in a Swedish population; impact of parity. Acta Obstet Gynecol Scand (2001) 1.01
Independent effects of maternal age and birth order on the incidence of selected congenital malformations. Teratology (1972) 0.94
Maternal hypertension, antihypertensive medication use, and the risk of severe hypospadias. Birth Defects Res A Clin Mol Teratol (2008) 0.93
Prior spontaneous abortion, prior elective termination, interpregnancy interval, and risk of neural tube defects. Am J Epidemiol (2000) 0.91
Maternal factors and disparities associated with oral clefts. Ethn Dis (2010) 0.91
The epidemiology of diaphragmatic hernia. Eur J Epidemiol (1997) 0.91
Role of maternal smoking and maternal reproductive history in the etiology of hypospadias in the offspring. Teratology (2002) 0.88
Pregnancy interruption after second trimester diagnosis of fetal structural anomalies: the New Jersey Fetal Abnormalities Registry. Am J Obstet Gynecol (2005) 0.88
Birth order and neural tube defects: a reappraisal. J Neurol Sci (2004) 0.87
Descriptive epidemiology of nonsyndromic omphalocele in Texas, 1999-2004. Am J Med Genet A (2009) 0.87
Gastroschisis prevalence in Texas 1999-2003. Birth Defects Res A Clin Mol Teratol (2010) 0.87
Amniotic band syndrome: a population-based study in two Australian states. Paediatr Perinat Epidemiol (1993) 0.84
Reference data representative of normal findings at three-dimensional power Doppler ultrasound examination of the cervix from 17 to 41 gestational weeks. Ultrasound Obstet Gynecol (2006) 0.82
Parity and hypertension. Vital Health Stat 11 (1972) 0.81
Rates of twinning before and after fortification of foods in the US with folic acid, Texas, 1996 to 1998. Paediatr Perinat Epidemiol (2003) 0.81
Influence of maternal parity, age, and ethnicity on risk of esophageal atresia in the infant in a population-based study. J Pediatr Surg (2008) 0.79
Some observations on the cause and treatment of hare-lip and cleft palate, based on the treatment of 1041 patients. Br J Surg (1959) 0.77
[Birth order in subjects with cleft lip and palate]. Dtsch Zahnarztl Z (1967) 0.77
Maternal miscarriage history and risk of anencephaly. Paediatr Perinat Epidemiol (2006) 0.76
Incidence and relation to parity of pregnancy-induced hypertension in Iceland. Acta Obstet Gynecol Scand (1989) 0.76
An epidemiologic study of cleft lip with or without cleft palate and posterior cleft palate in Hungary. Hum Hered (1971) 0.76
Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol (2010) 7.00
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79
Guidelines for case classification for the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2003) 3.75
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol (2011) 3.42
Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol (2007) 3.29
Diabetes mellitus and birth defects. Am J Obstet Gynecol (2008) 3.25
Seeking causes: Classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol (2007) 2.69
Periconceptional dietary intake of choline and betaine and neural tube defects in offspring. Am J Epidemiol (2004) 2.49
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Assisted reproductive technology and major structural birth defects in the United States. Hum Reprod (2008) 2.38
Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol (2008) 2.35
Maternal occupational exposure to organic solvents during early pregnancy and risks of neural tube defects and orofacial clefts. Occup Environ Med (2012) 2.35
Maternal exposure to ambient levels of benzene and neural tube defects among offspring: Texas, 1999-2004. Environ Health Perspect (2010) 2.16
Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14
Alcohol consumption by women before and during pregnancy. Matern Child Health J (2008) 1.94
Maternal periconceptional vitamins: interactions with selected factors and congenital anomalies? Epidemiology (2002) 1.93
Control selection and participation in an ongoing, population-based, case-control study of birth defects: the National Birth Defects Prevention Study. Am J Epidemiol (2009) 1.93
Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects. Am J Obstet Gynecol (2011) 1.89
Mortality in first 5 years in infants with functional single ventricle born in Texas, 1996 to 2003. Circulation (2010) 1.81
Differences in exposure assignment between conception and delivery: the impact of maternal mobility. Paediatr Perinat Epidemiol (2010) 1.76
118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet (2009) 1.74
Reduced risks of neural tube defects and orofacial clefts with higher diet quality. Arch Pediatr Adolesc Med (2011) 1.73
Maternal nutrient intakes and risk of orofacial clefts. Epidemiology (2006) 1.70
Maternal exposure to methotrexate and birth defects: a population-based study. Am J Med Genet A (2014) 1.70
Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol (2008) 1.69
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports. BMJ (2015) 1.68
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Maternal asthma medication use and the risk of gastroschisis. Am J Epidemiol (2008) 1.62
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Mid-pregnancy cotinine and risks of orofacial clefts and neural tube defects. J Pediatr (2008) 1.52
Maternal smoking and congenital heart defects. Pediatrics (2008) 1.49
Maternal hypertension, medication use, and hypospadias in the National Birth Defects Prevention Study. Obstet Gynecol (2014) 1.45
Epidemiologic characteristics of congenital diaphragmatic hernia among 2.5 million California births, 1989-1997. Birth Defects Res A Clin Mol Teratol (2006) 1.43
Antidepressant Prescription Claims Among Reproductive-Aged Women With Private Employer-Sponsored Insurance - United States 2008-2013. MMWR Morb Mortal Wkly Rep (2016) 1.43
Antiherpetic medication use and the risk of gastroschisis: findings from the National Birth Defects Prevention Study, 1997-2007. Paediatr Perinat Epidemiol (2013) 1.40
Using bayesian models to assess the effects of under-reporting of cannabis use on the association with birth defects, national birth defects prevention study, 1997-2005. Paediatr Perinat Epidemiol (2014) 1.39
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension (2009) 1.35
Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol (2007) 1.34
Including prenatal diagnoses in birth defects monitoring: Experience of the Metropolitan Atlanta Congenital Defects Program. Birth Defects Res A Clin Mol Teratol (2009) 1.33
Anencephaly and spina bifida among Hispanics: maternal, sociodemographic, and acculturation factors in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2009) 1.31
Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol (2010) 1.28
The National Birth Defects Prevention Study: A review of the methods. Birth Defects Res A Clin Mol Teratol (2015) 1.28
Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics (2011) 1.28
Medications in the first trimester of pregnancy: most common exposures and critical gaps in understanding fetal risk. Pharmacoepidemiol Drug Saf (2013) 1.25
Integration of DNA sample collection into a multi-site birth defects case-control study. Teratology (2002) 1.22
Herbal use before and during pregnancy. Am J Obstet Gynecol (2009) 1.21
The association of ambient air pollution and traffic exposures with selected congenital anomalies in the San Joaquin Valley of California. Am J Epidemiol (2013) 1.21
Bayesian methods for correcting misclassification: an example from birth defects epidemiology. Epidemiology (2009) 1.19
Risks of human conotruncal heart defects associated with 32 single nucleotide polymorphisms of selected cardiovascular disease-related genes. Am J Med Genet A (2005) 1.18
Maternal vasoactive exposures, amniotic bands, and terminal transverse limb defects. Birth Defects Res A Clin Mol Teratol (2009) 1.18
Frequency of holoprosencephaly in the International Clearinghouse Birth Defects Surveillance Systems: searching for population variations. Birth Defects Res A Clin Mol Teratol (2008) 1.18
Choline and risk of neural tube defects in a folate-fortified population. Epidemiology (2009) 1.18
Maternal occupational exposure to polycyclic aromatic hydrocarbons: effects on gastroschisis among offspring in the National Birth Defects Prevention Study. Environ Health Perspect (2012) 1.16
Maternal periconceptional smoking and alcohol consumption and risk for select congenital anomalies. Birth Defects Res A Clin Mol Teratol (2008) 1.15
Use of clomiphene citrate and birth defects, National Birth Defects Prevention Study, 1997-2005. Hum Reprod (2010) 1.15
Neural tube defects: an analysis of neighbourhood- and individual-level socio-economic characteristics. Paediatr Perinat Epidemiol (2009) 1.14
Socioeconomic status in relation to selected birth defects in a large multicentered US case-control study. Am J Epidemiol (2007) 1.14
Maternal reproductive and demographic characteristics as risk factors for hypospadias. Paediatr Perinat Epidemiol (2007) 1.13
Patterns in the prevalence of congenital heart defects, metropolitan Atlanta, 1978 to 2005. Birth Defects Res A Clin Mol Teratol (2013) 1.13
Use of antihistamine medications during early pregnancy and isolated major malformations. Birth Defects Res A Clin Mol Teratol (2009) 1.12
Proportion of neural tube defects attributable to known risk factors. Birth Defects Res A Clin Mol Teratol (2013) 1.11
Racial/Ethnic disparities in risk of early childhood mortality among children with congenital heart defects. Pediatrics (2011) 1.09
Use of antiepileptic medications in pregnancy in relation to risks of birth defects. Ann Epidemiol (2011) 1.08
Neural tube defects associated with maternal periconceptional dietary intake of simple sugars and glycemic index. Am J Clin Nutr (2003) 1.08
Maternal caffeine consumption and risk of neural tube defects. Birth Defects Res A Clin Mol Teratol (2009) 1.07
Trends of selected malformations in relation to folic acid recommendations and fortification: an international assessment. Birth Defects Res A Clin Mol Teratol (2006) 1.06
Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? Am J Med Genet A (2009) 1.05
Association between congenital heart defects and small for gestational age. Pediatrics (2007) 1.04
Maternal prepregnancy body mass index and risk of spontaneous preterm birth. Paediatr Perinat Epidemiol (2014) 1.04
Demographic and environmental risk factors for gastroschisis and omphalocele in the National Birth Defects Prevention Study. J Pediatr Surg (2009) 1.04
Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study. Drug Alcohol Depend (2010) 1.04
Endothelial nitric oxide synthase (NOS3) genetic variants, maternal smoking, vitamin use, and risk of human orofacial clefts. Am J Epidemiol (2005) 1.04
Epidemiologic characteristics of anophthalmia and bilateral microphthalmia among 2.5 million births in California, 1989-1997. Am J Med Genet A (2005) 1.04
Autoantibodies to folate receptor during pregnancy and neural tube defect risk. J Reprod Immunol (2008) 1.03
Chromosomal abnormalities among children born with conotruncal cardiac defects. Birth Defects Res A Clin Mol Teratol (2009) 1.02
Prevalence of self-reported infection during pregnancy among control mothers in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2009) 1.02
Ambient air pollution and traffic exposures and congenital heart defects in the San Joaquin Valley of California. Paediatr Perinat Epidemiol (2013) 1.02
Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004. Ann Epidemiol (2010) 1.02
Correlates of intake of folic acid-containing supplements among pregnant women. Am J Obstet Gynecol (2006) 1.02
Maternal body mass index and lifestyle exposures and the risk of bilateral renal agenesis or hypoplasia: the National Birth Defects Prevention Study. Am J Epidemiol (2008) 1.01
Risk factors for non-syndromic holoprosencephaly in the National Birth Defects Prevention Study. Am J Med Genet C Semin Med Genet (2010) 1.01
Maternal occupational exposure to polycyclic aromatic hydrocarbons and risk of neural tube defect-affected pregnancies. Birth Defects Res A Clin Mol Teratol (2012) 1.00
Fetal constraint as a potential risk factor for craniosynostosis. Am J Med Genet A (2010) 1.00
Maternal exposure to criteria air pollutants and congenital heart defects in offspring: results from the national birth defects prevention study. Environ Health Perspect (2014) 1.00